Cargando…

Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances

Tyrosinase is a copper-containing enzyme which is widely distributed in nature (e.g., bacteria, mammals, fungi) and involved in two consecutive steps of melanin biosynthesis. In humans, an excessive production of melanin can determine hyperpigmentation disorders as well as neurodegenerative processe...

Descripción completa

Detalles Bibliográficos
Autores principales: Vittorio, Serena, Dank, Christian, Ielo, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218907/
https://www.ncbi.nlm.nih.gov/pubmed/37240442
http://dx.doi.org/10.3390/ijms24109097
_version_ 1785048885095301120
author Vittorio, Serena
Dank, Christian
Ielo, Laura
author_facet Vittorio, Serena
Dank, Christian
Ielo, Laura
author_sort Vittorio, Serena
collection PubMed
description Tyrosinase is a copper-containing enzyme which is widely distributed in nature (e.g., bacteria, mammals, fungi) and involved in two consecutive steps of melanin biosynthesis. In humans, an excessive production of melanin can determine hyperpigmentation disorders as well as neurodegenerative processes in Parkinson’s disease. The development of molecules able to inhibit the high activity of the enzyme remain a current topic in medicinal chemistry, because the inhibitors reported so far present several side effects. Heterocycle-bearing molecules are largely diffuse in this sense. Due to their importance as biologically active compounds, we decided to report a comprehensive review of synthetic tyrosinase inhibitors possessing heterocyclic moieties reported within the last five years. For the reader’s convenience, we classified them as inhibitors of mushroom tyrosinase (Agaricus bisporus) and human tyrosinase.
format Online
Article
Text
id pubmed-10218907
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102189072023-05-27 Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances Vittorio, Serena Dank, Christian Ielo, Laura Int J Mol Sci Review Tyrosinase is a copper-containing enzyme which is widely distributed in nature (e.g., bacteria, mammals, fungi) and involved in two consecutive steps of melanin biosynthesis. In humans, an excessive production of melanin can determine hyperpigmentation disorders as well as neurodegenerative processes in Parkinson’s disease. The development of molecules able to inhibit the high activity of the enzyme remain a current topic in medicinal chemistry, because the inhibitors reported so far present several side effects. Heterocycle-bearing molecules are largely diffuse in this sense. Due to their importance as biologically active compounds, we decided to report a comprehensive review of synthetic tyrosinase inhibitors possessing heterocyclic moieties reported within the last five years. For the reader’s convenience, we classified them as inhibitors of mushroom tyrosinase (Agaricus bisporus) and human tyrosinase. MDPI 2023-05-22 /pmc/articles/PMC10218907/ /pubmed/37240442 http://dx.doi.org/10.3390/ijms24109097 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Vittorio, Serena
Dank, Christian
Ielo, Laura
Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances
title Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances
title_full Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances
title_fullStr Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances
title_full_unstemmed Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances
title_short Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances
title_sort heterocyclic compounds as synthetic tyrosinase inhibitors: recent advances
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218907/
https://www.ncbi.nlm.nih.gov/pubmed/37240442
http://dx.doi.org/10.3390/ijms24109097
work_keys_str_mv AT vittorioserena heterocycliccompoundsassynthetictyrosinaseinhibitorsrecentadvances
AT dankchristian heterocycliccompoundsassynthetictyrosinaseinhibitorsrecentadvances
AT ielolaura heterocycliccompoundsassynthetictyrosinaseinhibitorsrecentadvances